| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
|
Neth J Med
|
1998
|
1.98
|
|
2
|
Combination therapy with cisplatin: modulation of activity and tumour sensitivity.
|
Clin Oncol (R Coll Radiol)
|
1992
|
1.43
|
|
3
|
Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH).
|
Intensive Care Med
|
1997
|
1.35
|
|
4
|
Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
|
Cancer Res
|
1988
|
1.21
|
|
5
|
Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release.
|
Biomaterials
|
2000
|
1.20
|
|
6
|
Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.
|
J Natl Cancer Inst
|
1989
|
1.16
|
|
7
|
Vincristine pharmacokinetics after repetitive dosing in children.
|
Cancer Chemother Pharmacol
|
1999
|
1.14
|
|
8
|
Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
|
Br J Cancer
|
1996
|
1.12
|
|
9
|
Validity and reliability of self-reported exposure to environmental tobacco smoke in work offices.
|
J Occup Environ Med
|
1997
|
1.08
|
|
10
|
Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia.
|
J Pediatr
|
1994
|
1.07
|
|
11
|
Electrochemical and surface characterization of a nickel-titanium alloy.
|
Biomaterials
|
1998
|
1.05
|
|
12
|
Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancer.
|
J Clin Oncol
|
1999
|
0.97
|
|
13
|
4-Aminopyridine kinetics.
|
Clin Pharmacol Ther
|
1982
|
0.97
|
|
14
|
Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
|
Br J Cancer
|
1997
|
0.97
|
|
15
|
Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia.
|
Eur J Clin Microbiol Infect Dis
|
1995
|
0.96
|
|
16
|
[A patient with acute tubular necrosis as a consequence of drinking diethylene glycol-treated wine].
|
Ned Tijdschr Geneeskd
|
1987
|
0.96
|
|
17
|
The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
|
Br J Cancer
|
1990
|
0.94
|
|
18
|
Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer.
|
Lancet
|
2000
|
0.92
|
|
19
|
Impairment of organ function after oral ingestion of refined petrol.
|
Intensive Care Med
|
1988
|
0.92
|
|
20
|
Effective treatment of verapamil intoxication with 4-aminopyridine in the cat.
|
J Clin Invest
|
1984
|
0.89
|
|
21
|
Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.
|
Br J Cancer
|
1995
|
0.88
|
|
22
|
The use of an alum irrigation in the treatment of massive bladder haemorrhage.
|
Pharm Weekbl Sci
|
1989
|
0.87
|
|
23
|
A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.
|
Br J Cancer
|
1993
|
0.87
|
|
24
|
The uncoupling of biliary lipid from bile acid secretion by organic anions in the rat.
|
Gastroenterology
|
1990
|
0.87
|
|
25
|
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.
|
Br J Cancer
|
1999
|
0.86
|
|
26
|
Pharmacokinetics of high-dose oral and intravenous dexamethasone.
|
Ther Drug Monit
|
1999
|
0.86
|
|
27
|
Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic-acid-induced cellular differentiation of a murine embryonal carcinoma cell line.
|
Int J Cancer
|
1993
|
0.85
|
|
28
|
Vincristine disposition in children with acute lymphoblastic leukemia.
|
Med Pediatr Oncol
|
1995
|
0.85
|
|
29
|
Excretion of platinum into breast milk.
|
Lancet
|
1989
|
0.84
|
|
30
|
High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
|
Cancer Res
|
1989
|
0.84
|
|
31
|
Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion.
|
Ther Drug Monit
|
1999
|
0.83
|
|
32
|
Antidepressants self-poisoning and ICU admissions in a university hospital in The Netherlands.
|
Pharm World Sci
|
2000
|
0.83
|
|
33
|
An automated method for the bioanalysis of vincristine suitable for therapeutic drug monitoring and pharmacokinetic studies in young children.
|
Ther Drug Monit
|
2001
|
0.83
|
|
34
|
A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours.
|
Br J Cancer
|
2000
|
0.82
|
|
35
|
Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess.
|
Int J Tuberc Lung Dis
|
2004
|
0.82
|
|
36
|
Neurotoxicity caused by valacyclovir in a patient on hemodialysis.
|
Ther Drug Monit
|
1998
|
0.82
|
|
37
|
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
|
Br J Cancer
|
1997
|
0.82
|
|
38
|
Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
|
Anticancer Res
|
1996
|
0.81
|
|
39
|
A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin.
|
J Clin Oncol
|
1987
|
0.81
|
|
40
|
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
|
Int J Cancer
|
1990
|
0.80
|
|
41
|
Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and bone.
|
Eur J Surg Oncol
|
1996
|
0.80
|
|
42
|
Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.
|
Br J Cancer
|
1995
|
0.80
|
|
43
|
Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
|
Br J Cancer
|
1997
|
0.79
|
|
44
|
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.
|
J Clin Oncol
|
1991
|
0.79
|
|
45
|
Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.
|
Br J Cancer
|
1995
|
0.78
|
|
46
|
Phase I-II study of the addition of alpha-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of alpha-2a interferon and leucovorin.
|
Eur J Cancer
|
1993
|
0.78
|
|
47
|
Stability of the new anticancer platinum analogue 1,2-diaminomethyl-cyclobutane-platinum(II)-lactate (lobaplatin; D19466) in intravenous solutions.
|
Pharm Res
|
1992
|
0.78
|
|
48
|
Adsorptive voltametry to determine platinum levels in plasma from testicular cancer patients treated with cisplatin.
|
Ther Drug Monit
|
2001
|
0.78
|
|
49
|
4-aminopyridine; analysis of the substance and a method for the preparation of a solution for injection in man.
|
Pharm Acta Helv
|
1981
|
0.78
|
|
50
|
Hyperthermic isolated regional perfusion with cisplatin in the local treatment of spontaneous canine osteosarcoma: assessment of short-term effects.
|
J Surg Oncol
|
1995
|
0.78
|
|
51
|
Renal dysfunction following high-dose carboplatin treatment.
|
J Cancer Res Clin Oncol
|
1988
|
0.77
|
|
52
|
A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone.
|
J Clin Oncol
|
1989
|
0.77
|
|
53
|
4-Aminopyridine tablets; a method for the preparation. In-vitro and in-vivo studies.
|
Pharm Acta Helv
|
1982
|
0.77
|
|
54
|
Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review.
|
Pharm Weekbl Sci
|
1988
|
0.76
|
|
55
|
4-Aminopyridine and haemodialysis in the treatment of verapamil intoxication.
|
Hum Toxicol
|
1985
|
0.76
|
|
56
|
In vitro and in vivo modulation of multi-drug resistance with amiodarone.
|
Int J Cancer
|
1991
|
0.76
|
|
57
|
Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
|
Br J Cancer
|
1992
|
0.76
|
|
58
|
A prolonged methoxymorpholino doxorubicin (PNU-152243 or MMRDX) infusion schedule in patients with solid tumours: a phase 1 and pharmacokinetic study.
|
Br J Cancer
|
2000
|
0.75
|
|
59
|
[A child with puzzling complaints--does he have a disease?].
|
Ned Tijdschr Geneeskd
|
1999
|
0.75
|
|
60
|
Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days.
|
Br J Cancer
|
1990
|
0.75
|
|
61
|
Magnesium and phosphorus.
|
Lancet
|
1998
|
0.75
|
|
62
|
Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumours.
|
Cancer Chemother Pharmacol
|
2001
|
0.75
|
|
63
|
Treatment of 4-aminopyridine-poisoning after oral overdose; a proposal.
|
Pharm Acta Helv
|
1984
|
0.75
|
|
64
|
Sensitive method for the determination of vincristine in human serum by high-performance liquid chromatography after on-line column-extraction.
|
J Chromatogr
|
1991
|
0.75
|
|
65
|
[Regional isolation perfusion with cisplatinum in dogs with osteosarcoma of an extremity].
|
Tijdschr Diergeneeskd
|
1987
|
0.75
|
|
66
|
Clinical pharmacokinetics of (NPAz2)2NSOAz: 'SOAz'.
|
Cancer Chemother Pharmacol
|
1983
|
0.75
|
|
67
|
Influence of oral atropine or hyoscine on the absorption of oral diazepam.
|
Br J Anaesth
|
1982
|
0.75
|
|
68
|
Changed pharmacokinetics under the influence of age.
|
Pharm Weekbl Sci
|
1987
|
0.75
|
|
69
|
Determination of the antitumor agent SOAz (1,3,3,5,5 pentakis(aziridino)-1 lambda 6,2,4,6,3 lambda 5, 5 lambda 5 thia-triazadiphosphorine-1-oxide) by a gas chromatographic assay suitable for pharmacokinetic studies in man.
|
Cancer Chemother Pharmacol
|
1983
|
0.75
|
|
70
|
Effect of ultrafilterable platinum concentration on cisplatin and carboplatin cytotoxicity in human tumor and bone marrow cells in vitro.
|
Pharm Res
|
1994
|
0.75
|
|
71
|
Neurophysiological evaluation in children with Friedreich's ataxia.
|
Early Hum Dev
|
2009
|
0.75
|
|
72
|
Comparison of the precision of seven analytical methods for the H2O concentration in human serum and urine.
|
Clin Chim Acta
|
1987
|
0.75
|
|
73
|
Phase I and pharmacokinetic study of trans-N3P3Az2(NHMe)4.
|
Cancer Treat Rep
|
1987
|
0.75
|
|
74
|
Clinical and pharmaceutical aspects in acute poisoning.
|
Pharm Weekbl Sci
|
1992
|
0.75
|
|
75
|
Blood concentrations after accidental cyclosporin overdose.
|
Eur J Pediatr
|
1989
|
0.75
|
|
76
|
Treatment of severe parathion intoxication.
|
Vet Hum Toxicol
|
1979
|
0.75
|
|
77
|
Determination of monoureides in biological fluids by high-pressure-liquid-chromatography.
|
Arch Toxicol
|
1979
|
0.75
|
|
78
|
The bone collector: a new device.
|
Arch Otolaryngol
|
1978
|
0.75
|
|
79
|
Liquid-chromatographic determination of 4-aminopyridine in serum, saliva, and urine.
|
Clin Chem
|
1981
|
0.75
|
|
80
|
Pharmacokinetics of cyclosporine A after intravenous and oral administration in liver transplant patients measured with high-performance liquid chromatography.
|
Ther Drug Monit
|
1993
|
0.75
|